Navigation Links
A Statement From Larry Corey, MD, of the HIV Vaccine Trials Network Regarding the New HIV Infection Statistics Released Today by the Centers for Disease Control
Date:8/2/2008

SEATTLE, Aug. 2 /PRNewswire/ -- "The federal government's ability to more exactly measure the number of new HIV infections in the United States annually is a great statistical tool -- but that is all that it is. I interpret the new numbers this way: They remind us that HIV/AIDS continues to be a real public health problem in this country as well as in many developing nations around the globe. Despite recent setbacks in developing an effective vaccine to prevent HIV infection, I believe that a vaccine is our most promising weapon against new infections. The research community's commitment to find a vaccine must not waver."

Dr. Corey is the Principal Investigator of the HIV Vaccine Trials Network (HVTN) and co-director of the Vaccine and Infectious Diseases Institute, both at Fred Hutchinson Cancer Research Center in Seattle, WA.

About the HIV Vaccine Trials Network

The HVTN is an international collaboration of scientists and institutions whose goal is to accelerate the search for an HIV vaccine by sharing trial results and facilitating parallel, concurrent testing. The HVTN is a unique hybrid that combines the depth and diversity of the academic community and the flexibility of a commercial drug company. Working with industry and government, the HVTN seeks to expedite and coordinate the trial process, advancing vaccine candidates and building a body of knowledge about HIV vaccine trials. The HVTN is supported through a cooperative agreement with the National Institute of Allergy and Infectious Diseases, which is a component of the U.S. National Institutes of Health. The Network and NIAID have a close, cooperative working relationship, with shared attention to the intellectual and scientific issues.

Contact: Sarah Alexander

206-910-3801

salex@hvtn.org


'/>"/>
SOURCE HIV Vaccine Trials Network
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. VaxGen Files 2006 Financial Statements and Provides Cash Update
2. ARYx Therapeutics, Inc. Files Registration Statement for Initial Public Offering
3. Anacor Files Registration Statement for Initial Public Offering
4. IsoTis Files Definitive Proxy Statement
5. MAKO Surgical Corp. Files Registration Statement for Initial Public Offering of Common Stock
6. Statement on Direct-To-Consumer Genetic Testing
7. Coherent Announces Restatement Related to Stock-Based Compensation
8. XTL Biopharmaceuticals: AGM/EGM Statements
9. Statement from GPhA President and CEO Kathleen Jaeger on FDAs Generic Initiative
10. Symmetry Medical Discloses Accounting Issues at Sheffield, UK Operating Unit and Possible Restatement
11. CCPM Issues Statement on FDAs GIVE Initiative
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/12/2019)... ... November 12, 2019 , ... ... R&D, today announced that Immatics Biotechnologies , a clinical-stage biopharmaceutical company ... to streamline their R&D operations related to the discovery and development of ...
(Date:11/9/2019)... ... November 08, 2019 , ... ... (AI)-powered technology for use in pathology research, today announced the results of ... from patients enrolled in the phase 3 selonsertib studies (STELLAR). Strong correlations ...
(Date:11/5/2019)... ... November 05, 2019 , ... ... received CE Mark for its Fusion Bx 2.0 prostate fusion biopsy solution. By ... the Fusion Bx 2.0 will give urologists across Europe the ability to perform ...
(Date:11/2/2019)... NEW YORK (PRWEB) , ... October 31, 2019 ... ... just been released by pharma artificial intelligence pioneer tellic. drug360 brings tellic’s ... data. This new tool allows researchers to quickly uncover relationships between genes, diseases, ...
Breaking Biology Technology:
(Date:11/27/2019)... , ... November 26, 2019 , ... ... to their Glen Ellyn, IL practice for Invisalign® treatment. Invisalign orthodontics ... , Patients with a misaligned bite, also known as malocclusion, present both functional ...
(Date:11/20/2019)... ... November 20, 2019 , ... BioInformatics Inc., part of ... tools market, today announced the winners of the Life Science Industry Awards for the ... Life Science Industry Awards – Innovation: , Most Innovative New Product – Cell Biology, ...
(Date:11/19/2019)... ... November 19, 2019 , ... Hosted at the Las Vegas Convention ... 2019 is the largest gathering of MJBiz business professionals in the world. With ... benefit every sector, there is no show quite like it. Atlantic Ultraviolet will exhibit ...
Breaking Biology News(10 mins):